NDC 70710-1401-01 - CLOBETASOL PROPIONATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70710-1401
- Requested NDC
- 70710-1401-01
- Package NDCs from labels
- 70710-1401-1, 70710-1401-2, 70710-1401-4, 70710-1401-3, 70710-1401-01
- Manufacturer
- Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited
- Effective date
- 2022-10-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CLOBETASOL - Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2022-10-05 | HUMAN PRESCRIPTION DRUG LABEL |
| CLOBETASOL PROPIONATE OINTMENT USP, 0.05% | Preferred Pharmaceuticals, Inc. | 2022-04-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70710-1401-1 | CLOBETASOL PROPIONATE | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 70710-1401-1 | CLOBETASOL PROPIONATE | 15 g in 1 TUBE | OINTMENT | 15 | 6 | |
| 70710-1401-2 | CLOBETASOL PROPIONATE | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 70710-1401-2 | CLOBETASOL PROPIONATE | 30 g in 1 TUBE | OINTMENT | 30 | 6 | |
| 70710-1401-3 | CLOBETASOL PROPIONATE | 60 g in 1 TUBE | OINTMENT | 60 | 6 | |
| 70710-1401-3 | CLOBETASOL PROPIONATE | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 70710-1401-4 | CLOBETASOL PROPIONATE | 45 g in 1 TUBE | OINTMENT | 45 | 6 | |
| 70710-1401-4 | CLOBETASOL PROPIONATE | 1 in 1 CARTON | OINTMENT | 1 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70710-1401 | CLOBETASOL PROPIONATE OINTMENT [ZYDUS PHARMACEUTICALS USA INC.] | 6 | Current NDC, Legacy NDC, 8 package rows | 20221007_98a25409-e84e-452b-8dc5-ad87842398e1.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70710-1401-1 | GM - Gram | 70710-1401 | dca331a7-bcc8-4f19-a9f3-51fed30ef500 | 1 | 2019-04-11 |
| 70710-1401-2 | GM - Gram | 70710-1401 | 2d156802-6d97-4fa4-82fd-eefd8cfb2731 | 1 | 2019-04-11 |
| 70710-1401-3 | GM - Gram | 70710-1401 | abe4f473-b54e-44c6-b448-6ea1d8959a62 | 1 | 2019-04-11 |
| 70710-1401-4 | GM - Gram | 70710-1401 | 8d5330df-ae86-45ca-9c89-e40f20dda0ff | 1 | 2019-04-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Petroleum | WHITE PETROLATUM | Topco Associates LLC | cd7f1727-0b6e-4993-9820-43783994efa1 | 2026-02-13 | Warnings, Adverse reactions | 4T6H12BN9U |
| Skin Protectant | PETROLATUM | Wakefern Food Corp. | b799229b-f7ca-494c-afde-1fd096aef66e | 2026-02-13 | Warnings, Adverse reactions | 4T6H12BN9U |
| PETROLATUM | ISHANCARE HEMORRHOID CREAM | Shenzhen Ishan Technology Co., Ltd | d22536d0-b935-6a20-e053-2a95a90af3ed | 2026-02-12 | Warnings | 4T6H12BN9U |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | NorthStar RxLLC | 3d14fff7-f1af-4d15-96b4-88cfccad271f | 2026-02-11 | Adverse reactions | 861448 779619577M |
| Droptics Performance Eye Drops | NAPHAZOLINE HYDROCHLORIDE, PROPYLENE GLYCOL | Droptics LLC | 20fd6822-a7fd-4593-92bb-0a07260893e2 | 2026-02-09 | Warnings | 6DC9Q167V3 |
| Petrolatum | WHITE PETROLATUM | Retail Business Services, LLC | bf0c9494-0138-4346-9348-e235ca4d9e58 | 2026-02-06 | Warnings, Adverse reactions | 4T6H12BN9U |
| Advanced Healing | PETROLATUM | Retail Business Services, LLC | 6e9121c8-5eb9-4d0b-86c5-b892e14bdab8 | 2026-02-06 | Warnings | 4T6H12BN9U |
| Petrolatum | WHITE PETROLATUM | Retail Business Services, LLC | bf73c618-ed2f-4468-a51f-ff61c7b1f506 | 2026-02-06 | Warnings, Adverse reactions | 4T6H12BN9U |
| Petroleum | WHITE PETROLATUM | Salado Sales Inc. | f973e3a5-3b45-4842-99ce-dff676ae1f96 | 2026-02-06 | Warnings, Adverse reactions | 4T6H12BN9U |
| Petroleum Skin Protectant | WHITE PETROLATUM | Pharmacy Value Alliance, LLC | 0ce03cd1-c48d-45cf-b11f-08bade55dcb6 | 2026-02-05 | Warnings, Adverse reactions | 4T6H12BN9U |
| Signature Care Hemorrhoidal | MINERAL OIL, PETROLATUM, AND PHENYLEPHRINE HCI | Better Living Brands, LLC | 3c8b43f3-6e1e-499e-ba71-ffdf836f6743 | 2026-02-05 | Warnings | 4T6H12BN9U |
| 0.25 % PHENYLEPHRINE HCl HEMORRHOIDAL | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE | Nantong Health & Beyond Hygienic Products Inc. | 1cada0ae-3f0f-441c-a633-faa0a3009d2b | 2026-02-05 | Warnings | 4T6H12BN9U |
| Petroleum | WHITE PETROLATUM | Harris Teeter | de380df6-cc6e-4b2a-98de-fc08eeb6e8ea | 2026-02-04 | Warnings, Adverse reactions | 4T6H12BN9U |
| Petroleum | WHITE PETROLATUM | Hy-Vee, Inc. | 45867f42-9562-c111-e063-6394a90adb70 | 2026-02-04 | Warnings, Adverse reactions | 4T6H12BN9U |
| Petroleum Skin Protectant | WHITE PETROLATUM | Major Pharmaceuticals | 0e7e11c5-a1f8-43c4-b8a6-211491052404 | 2026-02-04 | Warnings, Adverse reactions | 4T6H12BN9U |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Sportpharm LLC | 88e3624d-b8bb-4e65-9250-4c51d2bbed16 | 2026-02-03 | Warnings | 4T6H12BN9U |
| Comforts Petroleum Jelly | WHITE PETROLATUM | KROGER | 3feb3638-1cdc-62d4-e063-6294a90a1d89 | 2026-02-03 | Warnings | 4T6H12BN9U |
| Petroleum Skin Protectant | WHITE PETROLATUM | Demoulas Super Markets, Inc | 702215f0-4cfd-4a23-b47a-da691c136634 | 2026-02-03 | Warnings, Adverse reactions | 4T6H12BN9U |
| Vitamin A D | LANOLIN, PETROLATUM | Kroger Co. | b4aa9b58-d95e-4dac-9a34-213482e8ca34 | 2026-02-02 | Warnings, Adverse reactions | 4T6H12BN9U |
| Optase | WHITE PETROLATUM, LANOLIN | Scope Health Inc | c1991caa-51b9-13d1-e053-2995a90a1293 | 2026-01-31 | Warnings | 4T6H12BN9U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.